DHX Company Co., Ltd. (KOSDAQ:031860)

South Korea flag South Korea · Delayed Price · Currency is KRW
693.00
+102.00 (17.26%)
At close: Apr 3, 2026
-39.48%
Market Cap 13.15B
Revenue (ttm) 14.51B
Net Income (ttm) -33.19B
Shares Out 18.98M
EPS (ttm) -1,885.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,766,793
Average Volume 2,395,026
Open 597.00
Previous Close 591.00
Day's Range 597.00 - 755.00
52-Week Range 202.00 - 1,783.00
Beta -0.60
RSI 60.48
Earnings Date Mar 27, 2026

About DHX Company

DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution; and meditech distribution. In addition, the company is involved in manufacture and distribution of computers and peripherals; investment and asset ma... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1979
Employees 23
Stock Exchange KOSDAQ
Ticker Symbol 031860
Full Company Profile

Financial Performance

In 2025, DHX Company's revenue was 14.51 billion, an increase of 52.05% compared to the previous year's 9.54 billion. Losses were -33.19 billion, 88.7% more than in 2024.

Financial Statements

News

There is no news available yet.